

1,402,062 filings since 2004 · latest accepted Nov 4, 2026, 8:08 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Sep 18, 2026 accepted 4:00 PM ET | INTIInhibitor Therapeutics, Inc. | 5.02Officer / director change5.07Shareholder vote | DocumentSEC ↗ |
Apr 1, 2026 accepted 4:05 PM ET | INTIInhibitor Therapeutics, Inc. | Reg FD disclosure |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Apr 1, 2026 accepted 8:00 AM ET | INTIInhibitor Therapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Feb 24, 2026 accepted 8:00 AM ET | INTIInhibitor Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Oct 27, 2025 accepted 8:34 PM ET | INTIInhibitor Therapeutics, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Dec 14, 2023 accepted 6:02 AM ET | INTIInhibitor Therapeutics, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Oct 18, 2023 accepted 9:54 AM ET | INTIInhibitor Therapeutics, Inc. | 5.02Officer / director change5.03Bylaws / fiscal year | DocumentSEC ↗ |
Aug 29, 2023 accepted 2:33 PM ET | INTIInhibitor Therapeutics, Inc. | 5.02Officer / director change5.03Bylaws / fiscal year | DocumentSEC ↗ |
May 31, 2023 accepted 4:30 PM ET | INTIInhibitor Therapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 19, 2022 accepted 5:01 PM ET | INTIInhibitor Therapeutics, Inc. | 1.01Material agreement1.02Agreement terminated5.01Change in control5.02Officer / director change | DocumentSEC ↗ |
Sep 15, 2022 accepted 5:06 PM ET | INTIInhibitor Therapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 3, 2022 accepted 4:17 PM ET | INTIInhibitor Therapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jan 18, 2022 accepted 4:15 PM ET | INTIInhibitor Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |